ITC announced that Apple lost the lawsuit and Apple Watch infringed Masimo's patent on blood oxygen technology

As we all know, Apple Watch can measure the blood oxygen saturation of the human body. In 2020, Masimo sued Apple Watch, claiming that it violated its own blood oxygen technology patent. Recently, Xiaobian got the news that Apple has lost the lawsuit, which means that Apple Watch has indeed violated Masimo's blood oxygen technology.

The United States International Trade Commission (ITC) announced that Apple lost the lawsuit.Masimo won the first round of U.S. trade case on banning the import of Apple Watch. Apple infringed Masimo's patent on blood oxygen technology

Masimo sued Apple for the first time in 2020, claiming that Apple Watch violated 10 patents and was also suspected of stealing trade secrets by hiring key personnel. Subsequently, Masimo sued again in 2021, and then specifically pointed out that the Apple Watch Series 6 should be banned from sale because the device violated five patents on blood oxygen measurement technology.

In October 2022, Apple also filed two lawsuits, accusing Masimo's W1 series smart watches of infringing a number of patents. Apple said that it was in the previous lawsuit that Masimo "carefully studied Apple's intellectual property" and obtained confidential information.

Apple should bring new blood oxygen saturation measurement technology to Apple Watch after this lawsuit. After all, many users buy Apple Watch for blood oxygen measurement technology. If there is no blood oxygen technology, the sales of Apple Watch may decline.